Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
11
Number of overlapping holdings
9.8%
% of IXJ's 113 holdings also in MEDX
36.7%
% of MEDX's 30 holdings also in IXJ
Overlap by Weight
Sector Drift (IXJ minus MEDX)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IXJ |
Weight in MEDX |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 9.6% | 18.6% | 9.6% |
|
JOHNSON & JOHNSON | 5.5% | 5.3% | 5.3% |
|
ABBVIE INC | 4.4% | 8.8% | 4.4% |
|
MERCK & CO. INC. | 2.9% | 3.5% | 2.9% |
|
AMGEN INC | 2.2% | 6.2% | 2.2% |
Position Highlights (Non-Overlapping Exposures)
IXJ Overweight Relative to MEDX
|
UNITEDHEALTH GROUP INC | 6.0% |
|
ABBOTT LABORATORIES | 3.3% |
 |
ROCHE HOLDING LTD | 3.2% |
|
NOVARTIS AG | 3.2% |
 |
ASTRAZENECA PLC | 3.0% |
 |
NOVO NORDISK A/S-B | 2.9% |
|
INTUITIVE SURGICAL INC | 2.5% |
|
THERMO FISHER SCIENTIFIC INC | 2.4% |
|
BOSTON SCIENTIFIC CORP | 2.0% |
|
GILEAD SCIENCES INC | 1.9% |
IXJ Underweight Relative to MEDX
|
ELI LILLY & CO | -9.1% |
|
NOVARTIS AG-ADR | -7.0% |
|
ASTRAZENECA PLC-SPONS ADR | -5.6% |
|
ALNYLAM PHARMACEUTICALS INC | -4.5% |
|
ABBVIE INC | -4.4% |
|
BRISTOL-MYERS SQUIBB CO | -4.3% |
 |
ALKERMES PLC | -4.1% |
|
AMGEN INC | -4.0% |
|
GLAXOSMITHKLINE PLC-SPON ADR | -2.7% |
|
CRISPR THERAPEUTICS AG | -2.6% |